Multiple sclerosis and Pco2 decreased

---

Gender of people who have Multiple Sclerosis and experienced Pco2 Decreased *:

• female: 88.89 %
• male: 11.11 %

Age of people who have Multiple Sclerosis and experienced Pco2 Decreased *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 11.11 %
• 30-39: 11.11 %
• 40-49: 16.67 %
• 50-59: 5.5600000000000005 %
• 60+: 55.56 %

Common co-existing conditions for these people *:

1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.56%
2. Headache (pain in head): 1 person, 5.56%

Common drugs taken by these people *:

1. Avonex: 9 people, 50.00%
2. Lipitor: 5 people, 27.78%
3. Fosamax: 5 people, 27.78%
4. Lexapro: 4 people, 22.22%
5. Femhrt: 4 people, 22.22%
6. Ampyra: 4 people, 22.22%
7. Celebrex: 4 people, 22.22%
8. Neurontin: 4 people, 22.22%
9. Folic Acid: 4 people, 22.22%
10. Gilenya: 3 people, 16.67%

Common symptoms for these people *:

1. Dyspnea (difficult or laboured breathing): 8 people, 44.44%
2. Blood Glucose Increased: 8 people, 44.44%
3. Blood Ph Increased: 7 people, 38.89%
4. Alanine Aminotransferase Increased: 7 people, 38.89%
5. Blood Bicarbonate Decreased: 6 people, 33.33%
6. Memory Loss: 6 people, 33.33%
7. Blood Sodium Decreased: 6 people, 33.33%
8. Po2 Decreased: 6 people, 33.33%
9. Haemoglobin Decreased: 6 people, 33.33%
10. Aspartate Aminotransferase Increased: 6 people, 33.33%

Do you take medications and have Pco2 decreased?

- Check whether Pco2 decreased is associated with a drug or a condition